{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pfam:PF12338",
      "entity_text" : "RBCs",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q99497",
      "entity_text" : "DJ-1",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "To this end, it should be stressed that oxidatively modified DJ-1 has been reported to be elevated in brain tissues of both PD and AD patients XREF_BIBR, and oxidized DJ-1 protein has been previously suggested to be a useful biomarker as it has been recently demonstrated that levels of DJ-1 oxidation at Cys 106 are elevated in the RBCs of unmedicated PD patients when compared to both medicated patients and controls XREF_BIBR.",
  "reading_complete" : "2020-08-04T11:05:29Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T11:04:10Z",
  "trigger" : "elevated",
  "evidence" : [ "DJ-1 oxidation at Cys-106 are elevated in the RBCs" ],
  "pmc_id" : "3518819",
  "score" : 0
}